Active	Status	Sponsor type	Region	Phase	Filter
3 Active 7 Inactive 10 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Geissler, Edward K
NCT04720326: Bioavailability and Practicability of Envarsus Versus Advagraf in Liver Transplant Recipients	Active, not recruiting	4	268	Europe	Tacrolimus Pill, Envarsus, Tacrolimus capsule, Advagraf	Edward Geissler, Chiesi Pharmaceuticals GmbH, Excelya	Prophylaxis Against Liver Transplant Rejection	01/24	10/26
TaC:Drop, NCT06268769: Tacrolimus C:D Ratio Measured in Renal Transplant Recipients Treated With Once-daily Prolonged-release Drugs	Recruiting	4	300	Europe	Tacrolimus Pill, Envarsus, Tacrolimus capsule, Advagraf	Edward Geissler, Chiesi Pharmaceuticals GmbH	Immunosuppression	12/26	09/29
Banas, Bernhard
TaC:Drop, NCT06268769: Tacrolimus C:D Ratio Measured in Renal Transplant Recipients Treated With Once-daily Prolonged-release Drugs	Recruiting	4	300	Europe	Tacrolimus Pill, Envarsus, Tacrolimus capsule, Advagraf	Edward Geissler, Chiesi Pharmaceuticals GmbH	Immunosuppression	12/26	09/29